COMPANY INSIGHT

Sponsored by Repsol 

Repsol Healthcare® a comprehensive range of polyolefins for pharmaceutical packaging and medical devices

Over 30 grades comprising high and low density polyethylene (HDPE, LDPE), ethylene vinyl acetate copolymers (EVA), and polypropylene (PP), that comply with the strictest medical and pharmaceutical industry standards.

R

epsol is a global multi-energy provider, which works to facilitate the transition towards an energy model with fewer emissions. It employs over 25,000 people, has assets in 35 countries, and sells its products to 10 million customers in more than 90 countries. It operates low-emission power generation assets and is developing various renewable photovoltaic and wind energy projects. The company is a pioneer in the development of initiatives for sustainable mobility with more efficient fuels and new solutions. It produces more than 700,000 barrels of oil equivalent per day. Technology and digitalization are pillars of the company, whose objective is to be zero net emissions in 2050, the first in the sector to assume this ambitious goal.


Repsol manufactures and markets a wide variety of chemical products, ranging from basic petrochemicals to derivatives. Repsol’s derivative chemicals include a broad range of polyolefins.

Repsol Healthcare®

The company's Repsol Healthcare® range currently encompasses 34 different polyolefin grades produced in designated and upgraded "pharma units" that applied particular protocols and training.


Their goal is to manufacture and sell polyolefins for pharmaceutical packaging and medical devices, offering the maximum quality, service, commitment, and compliance worldwide, keeping the patients’ safety as our number one priority.


The medical devices market is a highly innovative field, which seeks to meet the patients’ needs and improve comfort and well-being with new designs. The raw materials must comply with different regulations and be tested in various conditions before getting the approval that warrants the safety of use, which makes the entry of a new player into the market a slow-moving process.


Repsol’s latest addition to its range for pharmaceutical packaging and medical devices consists of new LDPE grades that offer converters a wide variety of alternatives designed to meet their needs as regards both melt flow index (0.3–20 g/10’) and density. These new grades allow converters to manufacture innovative containers, parts, and films using extrusion-coating, lamination, blown film extrusion, and injection pieces.


The LDPE extension of the range was possible due to the addition to the Repsol pharma family of the company’s LDPE plant in Sines, Portugal. This plant joins the previous units in Tarragona — for polypropylene (PP), low-density polyethylene (LDPE) and high-density polyethylene (HDPE) — and Puertollano, for ethylene-vinyl acetate (EVA) copolymers.


Repsol has upgraded some of its production units, to assure the best quality. They have also set up new protocols and operations to meet the best practices of the health industry as well as its demands for quality and hygiene.


Repsol’s Chemicals division focuses its strategy on the constant generation of value through differentiated products and services. With this latest addition, Repsol Healthcare® further strengthens the attributes that define the brand:

Repsol and the Circular Economy

In its commitment to sustainability, all Repsol polyolefins are 100% recyclable, and the company already offers its clients a complete portfolio of Circular Polyolefins. Furthermore, their goal is to ensure that 20% of their polyolefins contain recycled plastics by 2030. Furthermore, the company has three extensive petrochemical facilities, two of them located in Spain, Puertollano, and Tarragona, and another in Portugal, Sines. They focus their strategy on the constant generation of value through differentiated products and services.


Repsol has also obtained the ISCC Plus certification for all their petrochemical complexes. They are the first to certify all their complexes for the production of circular polyolefins that use oil as a raw material obtained from plastic waste not suitable for mechanical recycling. Also, the certification allows them to market other products such as styrene, polyols, and glycols as circulars.


By being able to guarantee the traceability of the waste used, the company can offer to its customers a product with recycled material for applications that demand high cleanliness and safety requirements such as medical and food packaging or cables.

Contact information

REPSOL

Mendez Álvaro, 44

28045 Madrid (Spain)

Tel.: +34 91 75 31 803

sacrq@repsol.com

chemicalsonline.repsol.com